Mount Sinai Beth Israel Cancer Treatment



Cancer Centers of New York – located at Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, and New York Eye and Ear Infirmary of Mount Sinai – include some of the most widely respected oncology programs in the city and country, where we care for more than 6,000 new patients each year and follow more than 24,000 cancer survivors. Cancer Centers of New York remains the only hospital system in the metropolitan area to earn network accreditation with commendation by the American College of Surgeons Commission on Cancer.

Pioneering research by our clinicians in head and neck, prostate, breast, gastrointestinal and hepatobiliary cancers have helped shape modern cancer care in the United States. Currently we are conducting more than 60 clinical trials and leading research on integrative oncology, survivorship, prevention and outcomes. Our commitment to integrative oncology and the patient experience has gained widespread attention and commendation. Our physicians are leaders in non-invasive and minimally invasive cancer treatments that focus on maximizing both the cure rate and quality of life.

Mount Sinai has one of the top cancer programs in the United States, according to the U.S. News & World Report Best Hospitals survey. We are a National Cancer Institute (NCI)-Designated Cancer Center.

Mount Sinai Health System employs a level of clinical experts found only at major academic medical centers. As a nationally recognized teaching medical institution, we offer the most advanced treatments for patients with all types of cancer. Our distinguished Mount Sinai cancer care teams along with our Cancer Network Affiliates provide exceptional medical, surgical, and radiation oncology services, as well as emerging treatment options throughout the metropolitan area. We collaborate with a range of specialized centers and programs to customize a care plan for you to ensure the best possible outcome.